Microvesicles derived from human bone marrow mesenchymal stem cells inhibit tumor growth

Area of Science:

• Oncology
• Cell Biology
• Biotechnology

Background:

• Mesenchymal stem cells (MSCs) exhibit dual roles in tumor progression, potentially promoting or inhibiting tumor growth.
• The tumor microenvironment facilitates intercellular communication, with microvesicles (MVs) playing a significant role.

Purpose of the Study:

• To investigate the effects of MVs derived from human bone marrow MSCs on the in vitro and in vivo growth of HepG2 hepatoma, Kaposi's sarcoma, and Skov-3 ovarian tumor cell lines.
• To determine if MSC-derived MVs can stimulate or inhibit tumor cell proliferation and survival.

Main Methods:

• In vitro assessment of MV effects on cancer cell cycle progression, apoptosis, and necrosis.
• In vivo evaluation of MSC-derived MVs administered intra-tumorally in SCID mice bearing established tumors from HepG2, Kaposi's sarcoma, and Skov-3 cell lines.

Main Results:

• MSC-derived MVs inhibited cell cycle progression in all tested tumor cell lines.
• MVs induced apoptosis in HepG2 and Kaposi's sarcoma cells and necrosis in Skov-3 cells.
• Intra-tumoral administration of MVs significantly suppressed the growth of established tumors in vivo.

Conclusions:

• MVs derived from human MSCs demonstrate potent anti-tumorigenic effects.
• These MVs inhibit the in vitro growth and survival of diverse tumor cell lines.
• MSC-derived MVs effectively inhibit the progression of established tumors in vivo, suggesting therapeutic potential.